29 June 2012
Repeated graft loss after orthotopic liver transplantation: A case report
Oskar KornasiewiczACDEF, Karol ZbrońskiABCE, Michał GrątABC, Krzysztof ZieniewiczD, Marek KawczykAGDOI: 10.12659/AOT.883232
Ann Transplant 2012; 17(2): 131-134
Abstract
Background: Multiple orthotopic liver transplantations (OLTx), although relatively uncommon, are the only known therapy for repeated graft failure. Moreover, re-transplantation (re-OLTx) of more than 2 grafts is sparsely reported thus far.
Case Report: We describe here 2 cases of patients who fulfilled the criteria for undergoing more than 2 OLTx. Each patient received 3 grafts in total. The primary early indication for the first re-OLTx in both cases was hepatic artery thrombosis (HAT). Prior to the second re-OLTx, both patients were in poor general condition. In 1 case, the second graft failed due to the recurrence of primary sclerosing cholangitis; the patient was re-transplanted electively 69 months after the primary re-OLTx. In the other case, the patient required a non-elective second re-OLTx within 1 month after the first re-OLTx due to primary graft failure. In both patients, the second and the third re-OLTs were performed using a veno-venous bypass with hepaticojejunostomy on an already existing Roux-en-Y loop. While 1 patient died postoperatively due to multi-organ failure, the other is alive with good synthetic liver function at 60 months after the last transplantation. The overall mortality rate of this procedure was thus 50%.
Conclusions: Although repeated OLT of more than 2 grafts is technically feasible and in selected patients can be a life-saving procedure, it is rarely performed. In our limited experience, it is burdened with relatively high mortality and morbidity, unspecified indications regarding patient selection, and competition between patients awaiting liver transplantation.
Keywords: hepatic artery thrombosis, re-transplantation, primary nonfunction
In Press
08 Mar 2024 : Original article
Association of Coronary Calcium Score on Cardiac PET During Pre-Kidney Transplant Assessment with Persisten...Ann Transplant In Press; DOI: 10.12659/AOT.943532
14 Mar 2024 : Original article
Impact of Blood Products Transfusion on Patients in the Immediate Post-Lung Transplant Period: A Cohort StudyAnn Transplant In Press; DOI: 10.12659/AOT.943652
14 Mar 2024 : Case report
Treatment of Cavernous Transformation of Portal Vein Caused by Hepatic Cystic Echinococcosis Using Ex Vivo ...Ann Transplant In Press; DOI: 10.12659/AOT.942358
15 Mar 2024 : Review article
Approaches and Challenges in the Current Management of Cytomegalovirus in Transplant Recipients: Highlighti...Ann Transplant In Press; DOI: 10.12659/AOT.941185
Most Viewed Current Articles
05 Apr 2022 : Original article
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
12 Jan 2022 : Original article
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
22 Nov 2022 : Original article
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860